Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPFZ.L Regulatory News (PFZ)

  • There is currently no data for PFZ

Form 8.3 - Pfizer Inc

12 Nov 2015 15:27

RNS Number : 5541F
JPMorgan Asset Management
12 November 2015
Β 

Β 

Β 

FORM 8.3

Β 

IRISH TAKEOVER PANEL

Β 

Β 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)

Β 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Β 

Β 

1. KEY INFORMATION

Β 

Name of person dealing (Note 1)

JPMorgan Asset Management

Company dealt in

Pfizer Inc.

Class of relevant security to which the dealings being disclosed relate (Note 2)

Ordinary Shares

Date of dealing

11 November 2015

Β 

Β 

2. INTERESTS AND SHORT POSITIONSΒ 

Β 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Β 

Β 

Β 

Long

Short

Β 

Β 

Number

(%)

Number

(%)

(1) Relevant securities

Β 

86,300,352 *

1.40

(2) Derivatives (other than options)

Β 

208,388

0.00

(3) Options and agreements to purchase/sell

Β 

Total

Β 

Β 86,508,740 *

1.40

*In addition to the dealings in section 3, there is an increase in the holding of 404 shares due to a transfer.

Β 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Β 

Class of relevant security:

Β 

Long

Short

Β 

Β 

Number

(%)

Number

(%)

(1) Relevant securities

Β 

(2) Derivatives (other than options)

Β 

(3) Options and agreements to purchase/sell

Β 

Total

Β 

Β 

Β 

Β 

Β 

3. DEALINGS (Note 4)

Β 

(a) Purchases and sales

Β 

Purchase/sale

Β 

Number of relevant securities

Price per unit

(USD)

Purchase

Purchase

Purchase

Purchase

Purchase

Purchase

Β 

Β 

Sale

Sale

Sale

Sale

Sale

Sale

Sale

Sale

Sale

Sale

Sale

Sale

Sale

Sale

Sale

Sale

215

219

281,059

161,219

120

56,910

Β 

Β 

18

336

8

2

43

223

1,383

120

683

1,285

10

44

4,000

293

18,129

180

33.7176 USD

33.7177 USD

33.7197 USD

33.7447 USD

33.8078 USD

33.8231 USD

Β 

Β 

33.6810 USD

33.6820 USD

33.6830 USD

33.7000 USD

33.7080 USD

33.7090 USD

33.7100 USD

33.7120 USD

33.7130 USD

33.7140 USD

33.7150 USD

33.7152 USD

33.7400 USD

33.7431 USD

33.7777 USD

33.7800 USD

Β 

Β 

Β 

Β 

Β 

(b) Derivatives transactions (other than options transactions)

Β 

Product name,

e.g. CFD

Nature of transaction (Note 6)

Number of relevant securities (Note 7)

Price per unit (Note 5)

Β 

Β 

Β 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Β 

Product name,

e.g. call option

Β 

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise

price

Type, e.g. American, European etc.

Expiry

date

Option money

paid/received per unit (Note 5)

Β 

Β 

(ii) Exercising

Β 

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

Β 

Β 

Β 

Β 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Β 

Nature of transaction (Note 8)

Β 

Details

Price per unit (if applicable) (Note 5)

Β 

Β 

Β 

Β 

Β 

4. OTHER INFORMATION

Β 

Agreements, arrangements or understandings relating to options or derivatives

Β 

Β 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Β 

Β 

Β 

Β 

Is a Supplemental Form 8 attached? (Note 9)

NO

Β 

Date of disclosure

12 November 2015

Contact name

Evangelos Galiatsatos

Telephone number

0207 742 6148

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A

Β 

Β 

Β 

The Notes on Form 8.3 can be viewed on the Panel's website at www.irishtakeoverpanel.ie.Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ISEBTBATMBTBBTA
Date   Source Headline
17th Nov 20153:32 pmRNSForm 8.3 - Pfizer Inc Amendment
17th Nov 20153:32 pmRNSForm 8.3 - Pfizer Inc
17th Nov 20153:21 pmRNSForm 8.3 - Pfizer Inc
17th Nov 20153:16 pmRNSForm 8.3 - [PFIZER INC]
17th Nov 20153:14 pmRNSForm 8.3 - Allergan plc
17th Nov 20152:56 pmBUSForm 8.3 - Pfizer Inc.
17th Nov 20152:45 pmRNSForm 8.3 - ALLERGAN PLC
17th Nov 20152:36 pmRNSForm 8.3 - PFIZER INC
17th Nov 20152:27 pmRNSForm 8.3 - Pfizer Inc.
17th Nov 20152:26 pmRNSRule 38.5 - Replacement Pfizer INC
17th Nov 20152:24 pmRNSForm 8.3 - Pfizer Inc
17th Nov 20152:23 pmRNSForm 8.3 - Allergan plc
17th Nov 20152:07 pmRNSForm 8.3 - Allergan Plc
17th Nov 201512:10 pmRNSForm 38.5a
17th Nov 201512:09 pmRNSForm 38.5b
17th Nov 201512:07 pmRNSForm 38.5b
17th Nov 201512:03 pmRNSForm 8.1 - [Pfizer Inc]
17th Nov 201511:55 amRNSForm 8.3 - Pfizer Inc.
17th Nov 201511:43 amRNSForm 38.5(b) - Pfizer Inc
17th Nov 201511:16 amRNSForm 38.5(a) - Pfizer Inc
17th Nov 201510:30 amRNSRule 38.5 - Pfizer INC
17th Nov 201510:29 amRNSRule 38.5 - Pfizer INC
17th Nov 201510:28 amRNSRule 38.5 - Pfizer INC
17th Nov 20157:00 amRNSForm 8.3 - Pfizer, Inc Replacement non material
16th Nov 20154:05 pmRNSForm 8.3 - Allergan PLC
16th Nov 20153:52 pmRNSForm 8.3 - PFIZER INC
16th Nov 20153:49 pmRNSForm 8.3 - PFIZER INC.
16th Nov 20153:34 pmRNSForm 8.3 - Pfizer Inc
16th Nov 20153:27 pmRNSForm 8.3 - Allergan plc
16th Nov 20153:25 pmRNSForm 8.3 - Allergan plc
16th Nov 20153:13 pmRNSForm 8.3 - Pfizer Inc
16th Nov 20153:12 pmRNSForm 8.3 - Pfizer Inc Amendment
16th Nov 20153:05 pmRNSForm 8.3 - [PFIZER INC]
16th Nov 20153:03 pmRNSForm 8.3 - Pfizer Inc
16th Nov 20153:02 pmBUSForm 8.3 - Pfizer Inc.
16th Nov 20152:47 pmRNSForm 8.3 - Pfizer, Inc.
16th Nov 20152:41 pmRNSForm 8.3 - Pfizer Inc
16th Nov 20152:28 pmRNSForm 8.3 - Allergan Plc
16th Nov 201512:03 pmRNSForm 38.5b
16th Nov 201512:03 pmRNSForm 8.1- [Pfizer]
16th Nov 201512:03 pmRNSForm 38.5a
16th Nov 201512:01 pmRNSForm 38.5b
16th Nov 201511:55 amRNSForm 8.3 - Pfizer Inc
16th Nov 201511:50 amRNSForm 38.5b
16th Nov 201511:49 amRNSForm 38.5(b) - Pfizer Inc
16th Nov 201511:32 amRNSForm 8.1a - Pfizer Inc
16th Nov 201511:10 amRNSRule 38.5 - Pfizer INC
16th Nov 201511:09 amRNSRule 38.5 - Pfizer INC
16th Nov 201511:09 amRNSRule 38.5 - Pfizer INC
13th Nov 20155:16 pmRNSForm 38.5(b) - Pfizer Inc. - Amendment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.